Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc. financial statements

Telomir Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 10.41M10-K
Cash and equivalentsUSD 7.29M10-Q

Telomir Pharmaceuticals, Inc. financials on 6ix · Telomir Pharmaceuticals, Inc. on 6ix